GlassScriptPhysician profile
Angela M Jones
NPI 1821169319
$835.08
in general payments reported to CMS, 2019-2025
15 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $256 · 2022: $32.50 · 2023: $270 · 2024: $153 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $546.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $135.28 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $124.97 | 2023 | Rexulti |
| Genentech USA, INC. | $106.00 | 2021 | |
| Lilly USA, LLC | $104.12 | 2024 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $93.23 | 2023 | Fasenra |
| Astellas Pharma US INC | $80.37 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $49.88 | 2024-2025 | Thinprep 2000 Processor, Aptima |
| Medtronic, INC. | $32.50 | 2022 | |
| Shield Therapeutics INC | $18.08 | 2023 | Accrufer |
| Novo Nordisk INC | $16.52 | 2025 | Wegovy |
| Pfizer INC. | $16.23 | 2024 | |
| Organon LLC | $15.81 | 2024 | |
| Jazz Pharmaceuticals INC. | $14.38 | 2021 | |
| Mayne Pharma Commercial LLC | $14.25 | 2025 | |
| Janssen Biotech, INC. | $13.46 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.